You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Privia Health raised its 2026 outlook across key financial metrics, targeting 6,000 clinicians and 23.9% adjusted EBITDA growth. It acquired American Choice Healthcare MSSP ACO for approximately $36 million, adding more than 36,000 attributed lives.
Privia Health Group, Inc. reported revenue of $657.0 million and net income attributable to the company of $13.5 million for the three months ended September 30, 2026, versus $580.4 million and $6.9 million in 2025. Adjusted EBITDA rose to $40.6 million from $38.2 million.
Privia Health Group, Inc. reported nine-month 2026 net income of $25.6M, up 85.9%, and Adjusted EBITDA of $114.7M, up 21.9%. It raised full-year 2026 guidance above the prior high end for all key metrics.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Privia Health delivered strong Q2 2026 results with 12.4% practice collections growth, 29% Adjusted EBITDA growth, and 310 bps of EBITDA margin expansion, and raised full-year 2026 guidance for attributed lives above the prior high end while lifting practice collections/GAAP revenue/care margin/platform contribution/EBITDA to the high or mid-to-high end of prior ranges.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Platform Contribution | $68.84M | FY2026 Q3 | -13.9% |
|
|
|||
| Adjusted EBITDA non-GAAP | $74.1M | For the Six Months Ended June 30 | — |
| Adjusted EBITDA Margin non-GAAP | 28.4% | Six Months Ended June 30, 2026 | — |
| Adjusted net income non-GAAP | $49.58M | Six Months Ended June 30, 2026 | — |
| Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – basic non-GAAP | $0.4 | Six Months Ended June 30, 2026 | — |
| Adjusted net income per share attributable to Privia Health Group, Inc. stockholders – diluted non-GAAP | $0.38 | Six Months Ended June 30, 2026 | — |
| Attributed Lives (as of end of period) | 1,647,000 | Six Months Ended June 30, 2026 | — |
| Care Margin non-GAAP | $260.9M | For the Six Months Ended June 30 | — |
| Implemented Providers (as of end of period) | 5,644 | Six Months Ended June 30, 2026 | — |
| Platform Contribution Margin non-GAAP | 52.1% | Six Months Ended June 30, 2026 | — |
| Practice Collections | $1.88B | For the Six Months Ended June 30 | — |
| Value-Based Care Attributed Lives | 1,647,000 | Three Months Ended June 30 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PRVA
this stock
Privia Health Group, Inc.
|
$3.14B | +3.5% | +22.3% | 90.9 | 3.1% |
|
VEEV
Veeva Systems Inc
|
$48.82B | +35.1% | +28.1% | 49.4 | 2.4% |
|
PMDIY
Pro Medicus Ltd.
|
$14.81B | -14.6% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$14.17B | +90.1% | +28.2% | 38.7 | 5.8% |
|
TEM
Tempus AI, Inc.
|
$13.06B | +21.3% | +83.4% | — | 13.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Privia Health Group, Inc. reported nine-month 2026 net income of $25.6M, up 85.9%, and Adjusted EBITDA of $114.7M, up 21.9%. It raised full-year 2026 guidance above the prior high end for all key metrics.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PRVA | +0.5% | +9.0% | +10.6% | +14.3% | +3.5% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.1% | +10.2% | +10.1% | +14.5% | -7.1% |
